Cargando…

Comparability Considerations and Challenges for Expedited Development Programs for Biological Products

Expedited development programs for biological products to be used in the treatment of serious conditions bring about challenges because of the compressed clinical development timeframes. As expedited development does not lessen the quality expectations, one challenge is providing adequate chemistry,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schrieber, Sarah J., Putnam, Wendy S., Chow, Edwin Chiu Yuen, Cieslak, Jacek, Zhuang, Yanli, Martin, Steven W., Hanson, Paul, Maggio, Frank, Rosado, Leslie A. Rivera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691403/ https://www.ncbi.nlm.nih.gov/pubmed/32914381 http://dx.doi.org/10.1007/s40268-020-00321-4

Ejemplares similares

Pharmacovigilance Considerations for Biosimilars in the USA
por: Grampp, Gustavo, et al.
Publicado: (2015)

Considerations for Effective Communication of Medical Information
por: Power, Eddie G. M.
Publicado: (2023)

Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials
por: Ott, Mary A., et al.
Publicado: (2018)

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2020)

Mpox and Monkeypox Virus: Special Considerations for Athletes in Contact Sports
por: Smoliga, James M.
Publicado: (2023)

Treatment Considerations for Compulsive Exercise in High-Performance Athletes with an Eating Disorder
por: Martenstyn, Jordan A., et al.
Publicado: (2022)

Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
por: Bouvy, Jacoline C., et al.
Publicado: (2018)

Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers
por: Kow, Chia Siang, et al.
Publicado: (2020)

Inevitable future: space colonization beyond Earth with microbes first
por: Lopez, Jose V, et al.
Publicado: (2019)

Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications
por: Gijsen, Frank, et al.
Publicado: (2019)

Methodological Considerations for Studies in Sport and Exercise Science with Women as Participants: A Working Guide for Standards of Practice for Research on Women
por: Elliott-Sale, Kirsty J., et al.
Publicado: (2021)

Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future
por: Mahfoud, Felix, et al.
Publicado: (2017)

Malaria and Economic Evaluation Methods: Challenges and Opportunities
por: Drake, Tom L., et al.
Publicado: (2017)

The Challenge of Applying and Undertaking Research in Female Sport
por: Emmonds, Stacey, et al.
Publicado: (2019)

Sea otter health: Challenging a pet hypothesis
por: Lafferty, Kevin D.
Publicado: (2015)

The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA
por: Baum, Charles, et al.
Publicado: (2015)

Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents
por: Kennedy, Mary Jayne, et al.
Publicado: (2013)

Financing Drug Innovation in the US: Current Framework and Emerging Challenges
por: Cutler, David, et al.
Publicado: (2020)

The Challenge of Maintaining Metabolic Health During a Global Pandemic
por: King, Andy J., et al.
Publicado: (2020)

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
por: van der Pol, Karel H., et al.
Publicado: (2023)

Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer
por: Barron, Anthony, et al.
Publicado: (2016)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?
por: Merlin, Tracy, et al.
Publicado: (2023)

Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them
por: Peters, Sheila Annie, et al.
Publicado: (2019)

Current Challenges in Labelling for Generic Medicinal Products: Company Core Data Sheet (CCDS) Development and Maintenance
por: Mueller, Marion, et al.
Publicado: (2020)

Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges
por: Sagili Anthony, Deva Priya, et al.
Publicado: (2021)

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
por: Bauchau, Vincent, et al.
Publicado: (2023)

Towards a more efficient healthcare system: Opportunities and challenges caused by hospital closures amid the COVID-19 pandemic
por: Saghafian, Soroush, et al.
Publicado: (2022)

Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond
por: Gieber, Lisa, et al.
Publicado: (2023)

Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
por: Navarese, Eliano Pio, et al.
Publicado: (2013)

Beyond convenience: practical considerations with using routine health data for evaluations
por: Watson-Grant, S, et al.
Publicado: (2020)

Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide
por: Kow, Chia Siang, et al.
Publicado: (2020)

Advancing community-engaged research to promote health equity: considerations to improve the field
por: Payán, DD, et al.
Publicado: (2021)

Comparability of Biologics: Global Principles, Evidentiary Consistency and Unrealized Reliance
por: Webster, Christopher J., et al.
Publicado: (2021)

Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015)

Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
por: Pimentel, Franklin Fernandes, et al.
Publicado: (2018)

Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
por: Park, Joseph P., et al.
Publicado: (2022)

Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?
por: George, Kelly, et al.
Publicado: (2019)

Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade(®)
por: Melsheimer, Richard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_035dtgguogt3c72h23l54cd8b9